LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹297 Cr | ₹263 Cr | ₹245 Cr | ₹182 Cr | ₹160 Cr |
What is the latest Total Non-Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹297 Cr |
| Mar2024 | ₹263 Cr |
| Mar2023 | ₹245 Cr |
| Mar2022 | ₹182 Cr |
| Mar2021 | ₹160 Cr |
How is Total Non-Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹297 Cr | 13.16 | |
| Mar2024 | ₹263 Cr | 6.96 | |
| Mar2023 | ₹245 Cr | 35.21 | |
| Mar2022 | ₹182 Cr | 13.74 | |
| Mar2021 | ₹160 Cr | - | |
Compare Total Non-Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,171.1 Cr | -2.5% | -5.6% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -2.5% |
-5.6% |
11.9% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses